甲状腺腺叶切除术后早期与晚期甲状腺功能减退的临床特征
该历史性队列研究纳入335例接受腺叶切除术的甲状腺微小乳头状癌(PTMC)患者,术后规律监测甲状腺功能并按特定标准决定左甲状腺素治疗。术后甲状腺功能减退发生215例(64.2%),其中5例(1.5%)为显性甲状腺功能减退、210例(62.7%)为亚临床甲状腺功能减退;40例(11.9%)需甲状腺激素替代。术前高促甲状腺激素(TSH)是预测术后甲状腺功能减退及甲状腺功能减退未恢复的最重要因素。
要点
- 腺叶切除术后甲状腺功能减退发生率为64.2%(215/335),需甲状腺激素替代者占11.9%(40/335)。
- 术前高TSH是预测术后甲状腺功能减退及未恢复的最重要因素(OR 2.82 和 1.77)。
- 术后1年TSH可区分晚期甲状腺功能减退与甲状腺功能正常(OR 2.29)。
核心结论
- 术前和术后TSH水平可能预测腺叶切除术后甲状腺功能减退的发生,并识别需要长期监测甲状腺功能减退的患者。
- 术后轻度甲状腺功能减退病例应随访而不立即给予左甲状腺素替代,期待其自发恢复。
研究设计与样本
- 历史性队列研究,纳入335例接受腺叶切除术的甲状腺微小乳头状癌(PTMC)患者。
- 术后定期测量甲状腺功能,按特定标准处方左甲状腺素;不符合激素替代标准的患者密切随访。
主要发现
- 术后甲状腺功能减退发生215例(64.2%),包括5例(1.5%)显性甲状腺功能减退和210例(62.7%)亚临床甲状腺功能减退。
- 40例(11.9%)需甲状腺激素替代;119例(33.5%)经历暂时性甲状腺功能减退并自发恢复至甲状腺功能正常状态。
- 术前高TSH是预测术后甲状腺功能减退和甲状腺功能减退未恢复的最重要因素(OR 2.82,95%CI 2.07至3.95,P<0.001;OR 1.77,95%CI 1.22至2.63,P=0.002)。
- 在最终发生术后甲状腺功能减退的215例患者中,70例(32.6%)在术后第一年之后发生甲状腺功能减退。
- 术后1年TSH水平能够区分发生晚期甲状腺功能减退或甲状腺功能正常的患者(OR 2.29,95%CI 1.68至3.26,P<0.001)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: Lobectomy is preferred in thyroid cancer to decrease surgical complications and avoid lifelong thyroid-hormone replacement. However, postoperative hypothyroidism, requiring thyroid-hormone replacement, may occur. OBJECTIVE: We aimed to identify the incidence and risk factors of postoperative hypothyroidism to develop a surveillance strategy after lobectomy for papillary thyroid microcarcinoma (PTMC). METHODS: This historical cohort study involved 335 patients with PTMC treated by lobectomy. Postoperative thyroid functions were measured regularly, and patients were prescribed levothyroxine according to specific criteria. Patients not satisfying hormone-replacement criteria were closely followed up. RESULTS: Postoperative hypothyroidism occurred in 215 patients (64.2%) including 5 (1.5%) with overt hypothyroidism and 210 (62.7%) with subclinical hypothyroidism. Forty patients (11.9%) were required thyroid hormone replacement. One hundred nineteen patients (33.5%) experienced temporary hypothyroidism and spontaneously recovered to euthyroid state. High preoperative thyroid-stimulating hormone (TSH) was the most important factor predicting postoperative hypothyroidism and failure of recover from hypothyroidism (odds ratio [OR], 2.82 and 1.77; 95% confidence interval [CI], 2.07 to 3.95 and 1.22 to 2.63; P < 0.001 and 0.002, respectively). Of the 215 patients eventually developing postoperative hypothyroidism, 70 (32.6%) developed hypothyroidism after the first postoperative year. Postoperative 1-year TSH levels were able to differentiate patients developing late hypothyroidism or euthyroidism (OR, 2.29; 95% CI, 1.68 to 3.26; P < 0.001). CONCLUSIONS: Preoperative and postoperative TSH levels might be predictive for patients who develop postlobectomy hypothyroidism and identify those requiring long-term surveillance for hypothyroidism. Additionally, mild postoperative hypothyroidism cases should be followed up without immediate levothyroxine replacement with the expectation of spontaneous recovery.
引用
- Park S, Jeon MJ, Song E, et al. Clinical Features of Early and Late Postoperative Hypothyroidism After Lobectomy. J Clin Endocrinol Metab. 2017. PMID: 28324106. doi:10.1210/jc.2016-3597
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。